Home > Insider Trading > Filing (0001012975-15-000075)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1454189	Auspex Pharmaceuticals Inc.	ASPX	Pharmaceutical Preparations (2834)	954862842

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1369574	Thomas, Mcnerney & Partners Ii L.p.	45 South Seventh Street Suite 3060 Minneapolis MN 55402	No	No	Yes	No
1383035	Tmp Associates Ii Lp	45 South Seventh Street Suite 3060 Minneapolis MN 55402	No	No	Yes	No
1436054	Tmp Nominee Ii, Llc	45 South Seventh Street Suite 3060 Minneapolis MN 55402	No	No	Yes	No
1505930	Thomas, Mcnerney & Partners Ii, Llc	45 South Seventh Street Suite 3060 Minneapolis MN 55402	Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-01-28	730,000	$53.11	4,835,731	No	4	S	Indirect	see footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	see footnote

Footnotes

The securities were sold to the underwriter by the Reporting Persons in connection with a secondary offering of the Issuer's securities as follows: 719,780 shares by Thomas, McNerney & Partners II, L.P. ("TMP II"), 7,519 shares by TMP Nominee II, LLC ("TMPN II") and 2,701 shares by TMP Associates II, L.P. ("TMPA II").
Includes 4,768,041 shares held in the name of TMP II; 49,805 shares held in the name of TMPN II; and 17,885 shares held in the name of TMPA II.
The securities are held in the name of TMP II, TMPN II and TMPA II. Thomas, McNerney & Partners II, LLC ("TMP II LLC") is the general partner of TMP II and TMPA II. TMP II LLC disclaims its beneficial interest in the reported securities except to the extent of its pecuniary interest.